Wednesday, May 8 2024 | Time 00:28 Hrs(IST)
image
Business EconomyPosted at: Oct 14 2022 4:26PM


C-CAMP signs pact with Agilent Technologies

Bengaluru, Oct 14 (UNI) The Centre for Cellular and Molecular Platform (C-CAMP) has signed an agreement with Agilent Technologies to pave the way for research and technology development in the sector of biosimilars and biopharmaceuticals, a core strength of both the organizations.
The agreement will primarily focus on mass spectrometry-based biotherapeutics/biosimilar characterization, a platform C-CAMP champions with its existing state-of-the art mass spectrometry facilities across proteomics, metabolomics, lipidomics, glycomics and biologics research.
Through this partnership, both organizations will leverage each other’s capabilities to hold joint training sessions and seminars for researchers across biopharma/biosimilars start-ups and established companies.
C-CAMP and Agilent will collaborate on product development and services for the biopharmaceutical industry, using the high-end scientific infrastructures and skill sets that both Agilent and C-CAMP share.
Dr Taslimarif Saiyed, C-CAMP CEO and Director, said: "C-CAMP is steadily growing in the area of biopharmaceuticals and this partnership will greatly benefit the delivery of deep-science technologies to the biopharma sector. With this MoU, the start-ups associated with C-CAMP can easily access their high-end mass spectrometry solutions and technologies."
Dr Shirshendu Mukherjee, Mission Director, BIRAC, congratulated both parties and said: "Science should not be limited to only bench level research and at BIRAC we are proud to have worked closely with C-CAMP in scouting for cutting-edge scientific ideas, converting them to technologies and solving important challenges while also exploiting their commercial potential.
"This partnership is a win-win for both C-CAMP and Agilent as it will provide access to high-end technology platforms such as Agilent’s to researchers, innovators and startups during the crucial product development phase."
Dr Samir Vyas, Agilent India Country General Manager, said: "This is a unique collaboration in India where Agilent’s partnership has a greater vision to align with a flagship program named ‘Innovate in India (I3)’, enabling an ecosystem to promote entrepreneurship and manufacturing capabilities."
C-CAMP facilitates bioscience research and innovation by providing training and services in addition to funding, incubation and entrepreneurship development support.
The organization is registered under the United States Food and Drug Administration (US FDA) to perform analyses towards active pharmaceutical ingredients, drug products, and drug substances.
With Agilent’s support, C-CAMP will be catalysing more research and development of biopharmaceuticals in compliance with the global regulatory framework in India.
C-CAMP is one of India’s premier innovation and technology hubs as well as one of the largest and most vibrant life sciences incubators in the country.
Agilent Technologies is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life.
The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide.
UNI BDN MR
Please log in to get detailed story.
Tags: #C-CAMP signs pact with Agilent Technologies
More News

YES BANK, global co EBANX announce partnership for payment processing in India

07 May 2024 | 7:16 PM

New Delhi, May 7 (UNI) India's private sector bank YES BANK, and EBANX, a global fintech company specialised in payment solutions for emerging markets, on Tuesday announced a strategic partnership for payment processing in India, for the global digital economy.

see more..

Agri Startup Hectar Global expands into Bangladesh

07 May 2024 | 7:07 PM

Chennai, May 7 (UNI) B2B cross-border agri-trade startup Hectar Global today announced its strategic expansion into the Bangladesh market to strengthen its downstream trade capabilities.

see more..

Shyam Metalics Group commences operation at recently acquired Ramsarup Plant

07 May 2024 | 6:06 PM

Kolkata, May 07 (UNI) Shyam Metalics and Energy Ltd, the metals manufacturing company, has announced the commencement of operation at recently acquired Ramsarup plant following its indirect acquisition through its wholly owned subsidiary Shyam Sel and Power Limited in May 2022.

see more..
Indian stock market bleeds; Sensex plunges over 383 points

Indian stock market bleeds; Sensex plunges over 383 points

07 May 2024 | 6:03 PM

Mumbai, May 7 (UNI) Snubbing the rally in the foreign bourses, India’s stock market plunged nearly 400 points as the 30-share sensex ended at 73511.85 for the day, down 383.69 points from previous close.

see more..

Jindal Stainless supplies spl alloy steel in DRDO’s SMART system for Navy

07 May 2024 | 5:37 PM

New Delhi, May 7 (UNI) Integrated steel maker Jindal Stainless on Tuesday said it has developed a specialized 3mm special alloy steel to be used for structural application in the Supersonic Missile – Assisted Release of Torpedo (SMART) system, aimed at enhancing Navy’s anti-submarine warfare capabilities.

see more..
image